Concepedia

Taddese Desta

TD

Statistics

Publications

5

Citations

662

H-Index

5

Active since

1998

Affiliations

Precision Research Institute(Current)

University of California Davis Medical Center

Taddese Desta is an author at Precision Research Institute specializing in pharmacotherapy, medicine, and antibiotic resistance.

Publications per year

1998–2021

5

Publications

5

A phase III study evaluating the efficacy and safety of remimazolam (CNS 7056) compared with placebo and midazolam in patients undergoing colonoscopy

Douglas K. Rex, Raj Bhandari, Taddese Desta et al. · Gastrointestinal Endoscopy · 2018 · 304 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +6

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 135 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

EDP-305 in patients with NASH: A phase II double-blind placebo-controlled dose-ranging study

Vlad Ratziu, Mary E. Rinella, Brent A. Neuschwander‐Tetri et al. · Journal of Hepatology · 2021 · 112 citations

Medicine, Internal Medicine, Pharmacology +2

Is there a synergistic effect between mixed bacterial infection in biofilm formation on biliary stents?

Joseph W. Leung, Yan Lei Liu, Taddese Desta et al. · Gastrointestinal Endoscopy · 1998 · 67 citations

Life Sciences, Infectious Diseases, Microbiology +16

In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage

Joseph W. Leung, Yanlei Liu, Taddese Desta et al. · Gastrointestinal Endoscopy · 2000 · 44 citations

Pharmacy, Pharmacotherapy, Surgery +16

1–5 of 5